Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-25 Sale | 2024-07-26 5:02 pm | Editas Medicine Inc. | EDIT | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | 11,886 | $5.4156 | $64,370 | 73,136 (Direct) | View |
| 2024-07-19 Sale | 2024-07-22 5:01 pm | Editas Medicine Inc. | EDIT | Mei Baisong EVP, CHIEF MEDICAL OFFICER | 6,619 | $5.2056 | $34,456 | 134,413 (Direct) | View |
| 2024-06-04 Sale | 2024-06-06 4:17 pm | Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO | 12,191 | $5.4956 | $66,997 | 315,279 (Direct) | View |
| 2024-06-04 Sale | 2024-06-06 4:16 pm | Editas Medicine Inc. | EDIT | Mei Baisong EVP, CHIEF MEDICAL OFFICER | 511 | $5.4956 | $2,808 | 141,032 (Direct) | View |
| 2024-05-20 Sale | 2024-05-22 4:30 pm | Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | 22,337 | $5.6142 | $125,404 | 116,829 (Direct) | View |
| 2024-05-13 Purchase | 2024-05-14 4:17 pm | Editas Medicine Inc. | EDIT | Hopfield Jessica Director | 45,000 | $5.6415 | $253,868 | 67,700 (Direct) | View |
| 2024-03-05 Sale | 2024-03-05 8:00 pm | Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO | 77,824 | $9.4172 | $732,884 | 719,570 (Direct) | View |
| 2024-03-04 Sale | 2024-03-05 7:54 pm | Editas Medicine Inc. | EDIT | Mei Baisong SVP, CHIEF MEDICAL OFFICER | 20,327 | $9.4173 | $191,425 | 294,343 (Direct) | View |
| 2023-12-05 Sale | 2023-12-07 4:30 pm | Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO | 103 | $10.9 | $1,122 | 74,791 (Direct) | View |
| 2023-11-14 Sale | 2023-11-16 4:30 pm | Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO | 695 | $8.2096 | $5,706 | 74,894 (Direct) | View |
| 2023-11-07 Sale | 2023-11-09 4:31 pm | Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO | 139 | $8.4 | $1,168 | 75,589 (Direct) | View |
| 2023-09-06 Sale | 2023-09-07 4:59 pm | Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO | 103 | $8.82 | $908 | 75,728 (Direct) | View |
| 2023-08-11 Sale | 2023-08-15 4:30 pm | Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO | 702 | $8.5935 | $6,033 | 75,831 (Direct) | View |
| 2023-08-08 Sale | 2023-08-10 4:30 pm | Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO | 141 | $8.39 | $1,183 | 76,533 (Direct) | View |
| 2023-07-19 Sale | 2023-07-21 4:30 pm | Editas Medicine Inc. | EDIT | Mei Baisong SVP, CHIEF MEDICAL OFFICER | 4,317 | $8.8 | $37,990 | 72,055 (Direct) | View |
| 2023-06-05 Sale | 2023-06-07 4:30 pm | Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO | 6,486 | $9.5032 | $61,638 | 130,169 (Direct) | View |
| 2023-06-05 Sale | 2023-06-07 4:30 pm | Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO | 105 | $9.503 | $998 | 76,674 (Direct) | View |
| 2023-05-11 Sale | 2023-05-15 4:30 pm | Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER | 949 | $9.872 | $9,369 | 106,610 (Direct) | View |
| 2023-05-11 Sale | 2023-05-15 4:30 pm | Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO | 668 | $9.872 | $6,594 | 76,779 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Option Award | 2024-06-03 5:15 pm | N/A 2034-05-29 | Editas Medicine Inc. | EDIT | Scadden David Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 5:14 pm | N/A 2034-05-29 | Editas Medicine Inc. | EDIT | Hopfield Jessica Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 5:13 pm | N/A 2034-05-29 | Editas Medicine Inc. | EDIT | Chatterjee Meeta Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 5:11 pm | N/A 2034-05-29 | Editas Medicine Inc. | EDIT | Hirsch Andrew Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:30 pm | N/A 2034-05-29 | Editas Medicine Inc. | EDIT | Reeve Emma Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:27 pm | N/A 2034-05-29 | Editas Medicine Inc. | EDIT | Levy Elliott M. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:25 pm | N/A 2034-05-29 | Editas Medicine Inc. | EDIT | Connaughton Bernadette Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 4:22 pm | N/A 2034-05-29 | Editas Medicine Inc. | EDIT | Vaishnaw Akshay Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-03-02 Option Award | 2024-03-05 8:06 pm | N/A 2034-03-01 | Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | 167,266 | $0 | 245,166 (Direct) | View |
| 2024-03-02 Option Award | 2024-03-05 8:03 pm | N/A 2034-03-01 | Editas Medicine Inc. | EDIT | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | 114,255 | $0 | 159,422 (Direct) | View |
| 2024-03-02 Option Award | 2024-03-05 8:00 pm | N/A 2034-03-01 | Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO | 667,225 | $0 | 719,570 (Direct) | View |
| 2024-03-02 Option Award | 2024-03-05 7:54 pm | N/A 2034-03-01 | Editas Medicine Inc. | EDIT | Mei Baisong SVP, CHIEF MEDICAL OFFICER | 242,615 | $0 | 294,343 (Direct) | View |
| 2023-07-24 Option Award | 2023-07-25 4:45 pm | N/A 2033-07-23 | Editas Medicine Inc. | EDIT | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | 180,667 | $0 | 180,667 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:30 pm | N/A 2033-05-31 | Editas Medicine Inc. | EDIT | Hopfield Jessica Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:30 pm | N/A 2033-05-31 | Editas Medicine Inc. | EDIT | Connaughton Bernadette Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:30 pm | N/A 2033-05-31 | Editas Medicine Inc. | EDIT | Reeve Emma Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:30 pm | N/A 2033-05-31 | Editas Medicine Inc. | EDIT | Vaishnaw Akshay Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:30 pm | N/A 2033-05-31 | Editas Medicine Inc. | EDIT | Hirsch Andrew Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:30 pm | N/A 2033-05-31 | Editas Medicine Inc. | EDIT | Scadden David Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:30 pm | N/A 2033-05-31 | Editas Medicine Inc. | EDIT | Chatterjee Meeta Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-18 5:20 pm | N/A 2033-05-16 | Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | 233,700 | $0 | 233,700 (Direct) | View |